1-9 of 9
Saad Z. Usmani
Close
Sort by
Journal Articles

Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies

Anna J. Howard, Isabel Concepcion, Alice X. Wang, Issam S. Hamadeh, Malin Hultcrantz, Sham Mailankody, Carlyn Tan, Neha Korde, Alexander M. Lesokhin, Hani Hassoun, Urvi A. Shah, Kylee H. Maclachlan, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Oscar B. Lahoud, David J. Chung, Sergio Giralt, Saad Z. Usmani, Ross S. Firestone
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3246–3253.
https://doi.org/10.1182/bloodadvances.2024012871
Published: 2024
Includes: Supplemental data
Journal Articles

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Clinical Trials & Observations
Issam S. Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S. Firestone, Alice X. Wang, Neha Korde, Malin L. Hultcrantz, Alexander M. Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A. Shah, Kylee Maclachlan, Sridevi Rajeeve, Dhwani Patel, Gunjan L. Shah, Michael Scordo, Oscar B. Lahoud, David J. Chung, Heather J. Landau, Sergio Giralt, Saad Z. Usmani, Carlyn R. Tan
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3038–3044.
https://doi.org/10.1182/bloodadvances.2024012724
Published: 2024
Journal Articles

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

Ross S. Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn R. Tan, Malin Hultcrantz, Sham Mailankody, Hani Hassoun, Urvi S. Shah, Neha Korde, Kylee H. Maclachlan, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Oscar B. Lahoud, Sergio Giralt, Kazunori Murata, Kinga K. Hosszu, David J. Chung, Alexander M. Lesokhin, Saad Z. Usmani
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1600–1611.
https://doi.org/10.1182/bloodadvances.2023011225
Published: 2024
Includes: Supplemental data
Journal Articles

Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population

Clinical Trials & Observations
Janine M. Joseph, Jens Hillengass, Li Tang, Alexander M. Lesokhin, Ola Landgren, Saad Z. Usmani, Kirsten B. Moysich, Susan E. McCann, Urvi A. Shah
Journal: Blood Advances
Blood Adv (2024) 8 (3): 538–548.
https://doi.org/10.1182/bloodadvances.2023011608
Published: 2024
Includes: Supplemental data
Journal Articles

Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX

Clinical Trials & Observations
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z. Orlowski, Sung-Soo Yoon, Saad Z. Usmani, Katja Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J. Blake Bartlett, Robin Carson, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2024) 8 (2): 388–398.
https://doi.org/10.1182/bloodadvances.2023010579
Published: 2024
Includes: Supplemental data
Journal Articles

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

Clinical Trials & Observations
Urvi A. Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R. Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud, Larysa Sanchez, Cesar Rodriguez, Shambavi Richard, Joshua Richter, Adriana Rossi, Hearn Jay Cho, Alexander Lesokhin, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Samir Parekh, Emily J. Gallagher
Journal: Blood Advances
Blood Adv (2024) 8 (1): 236–247.
https://doi.org/10.1182/bloodadvances.2023010815
Published: 2024
Includes: Supplemental data
Journal Articles

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

Clinical Trials & Observations
Saad Z. Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios Dimopoulos
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3739–3748.
https://doi.org/10.1182/bloodadvances.2023010026
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

Brittany Knick Ragon, Mithun Vinod Shah, Anita D’Souza, Noel Estrada-Merly, Lohith Gowda, Gemlyn George, Marcos de Lima, Shahrukh Hashmi, Mohamed A. Kharfan-Dabaja, Navneet S. Majhail, Rahul Banerjee, Ayman Saad, Gerhard C. Hildebrandt, Hira Mian, Muhammad Bilal Abid, Minoo Battiwalla, Lazaros J. Lekakis, Sagar S. Patel, Hemant S. Murthy, Yago Nieto, Christopher Strouse, Sherif M. Badawy, Samer Al Hadidi, Bhagirathbhai Dholaria, Mahmoud Aljurf, David H. Vesole, Cindy H. Lee, Attaphol Pawarode, Usama Gergis, Kevin C. Miller, Leona A. Holmberg, Aimaz Afrough, Melhem Solh, Pashna N. Munshi, Taiga Nishihori, Larry D. Anderson, Jr., Baldeep Wirk, Gurbakhash Kaur, Muzaffar H. Qazilbash, Nina Shah, Shaji K. Kumar, Saad Z. Usmani
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2746–2757.
https://doi.org/10.1182/bloodadvances.2022009138
Published: 2023
Includes: Supplemental data
Journal Articles

Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations

Kylee H. Maclachlan, Tina Bagratuni, Efstathios Kastritis, Bachisio Ziccheddu, Sydney Lu, Venkata Yellapantula, Chris Famulare, Kimon Argyropoulos, Andriy Derkach, Elli Papaemmanuil, Ahmet Dogan, Alexander Lesokhin, Saad Z. Usmani, C. Ola Landgren, Lia M. Palomba, Francesco Maura, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2023) 7 (6): 971–981.
https://doi.org/10.1182/bloodadvances.2022008876
Published: 2023
Includes: Supplemental data